An AI system performed better than junior doctors to diagnose patients with eye problems, according to a study published in the journal PLOS Digital Health. The authors from the University
All posts in artificial intelligence
“A high-tech health centre is the concrete application of digital health” – Clément Pacaud (Visiomed)
- Public Health -
Clément Pacaud, Managing Director of Visiomed, operator of the “Smart Salem” high-tech health centres in the Middle East, talks to European Scientist. The market is booming, with improvements in prevention,
Artificial Intelligence (AI) can be used to predict if adult patients with brain cancer are likely to survive more than eight months after receiving treatment, according to a study published
A team of researchers from Amsterdam UMC is planning to build models to enable greater access to AI systems in the healthcare sector. Most of our medical information is unstructured.
As artificial intelligence (AI) becomes more realistic, how does it affect our communication with others? A team of researchers from the University of Gothenburg, Germany, explores whether our trust in
The challenges of the convergence of Data, AI, Cloud, Blockchain, IoT and Cybersecurity
- Features -
The purpose of this article is to explain the relationships (dependencies, interdependencies, interrelationships, benefits) between Data, AI, Cybersecurity, Cloud, IoT and Blockchain, and to understand their consistency. The link between
Artificial Intelligence (AI) model shows how disease-causing bacteria, like E. coli for example, cause infection by injecting a cocktail of many different proteins knows as effectors into the host cell.
2020 was a promising year that many of us were impatiently expecting. Space launches, 5G and robotic innovations were some of the most-anticipated projects for this year. Until the coronavirus
Information about the novel coronavirus, SARS-CoV-2, and the disease it causes, COVID-19, is accumulating at a stellar rate. However, infections remain difficult to diagnose from symptoms alone, with cases ranging
In the September 2019 issue of Nature Biotechnology, a collective of scientists mostly from Insilico Medicine, led by Alex Zhavoronkov, CEO and founder of the company, published a landmark article.